Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.37
-0.0200-0.19%
Post-market: 10.370.00000.00%17:13 EDT
Volume:236.01K
Turnover:2.44M
Market Cap:518.51M
PE:-8.98
High:10.55
Open:10.39
Low:10.15
Close:10.39
Loading ...
Jul 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
May 03, 2023

Major Issues Report

8-K - Current report
Apr 17, 2023

Major Issues Report

8-K - Current report
Apr 14, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 11, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Major Issues Report

8-K/A [Amend] - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals